MENU
CPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Catalyst Pharmaceuticals (CPRX) Ownership - Who owns Catalyst Pharmaceuticals?

Profile

Industry
Pharmaceuticals Other
Address
355 Alhambra Circle
Phone
+1 305 420-3200
Employees
167
Web
https://www.catalystpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.58B
P/E Ratio
18.70
Total Cash
442.33M
Projected Growth
N/A
Total Debt
3.28M
Revenue
460.48M
Risk (Beta)
0.96
Dividend Yield
N/A
Total Cash/Share
3.71
Total Debt/Equity
N/A
Revenue/Share
3.78 USD as % of share price

Fundamentals

CPRX
Capitalization
2.58B
P/E Ratio
18.70
Risk (Beta)
0.96
Dividend Yield
N/A
Total Cash
442M
Total Cash/Share
3.71
Total Debt
3.28M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.78%
Revenue
460M
ROE
N/A
Book Value
661M
P/B Ratio
3.98
Cash Flow
N/A
Earnings
1.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
119K
Current Ratio
5.11
Current Revenue Per Employee
770628.75
Dividends Per Share - Security
N/A
EBITDA
211M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.02
Revenue To Assets
24.10
Shares Held By Institutions
2.87B
Shares Outstanding - Current
119M
Total Liabilities
111M
Total Volume MTD
N/A
Value
N/A
Gain YTD
31.291
View a ticker or compare two or three
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of prescription drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
355 Alhambra Circle
Phone
+1 305 420-3200
Employees
167
Web
https://www.catalystpharma.com